DJIA 17,730.11 0.00 0.00%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 0.00 0.00%
market minute promo

2.50 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

BLRX $2.50 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.61
Previous Close $2.50
Daily Range $2.38 - $2.63
52-Week Range $1.20 - $3.28
Market Cap $9.8M
P/E Ratio -2.21
Dividend (Yield) $0.00 (0.0%)
Volume 1,491,614
Average Daily Volume 1,140,264
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drug Makers

BioLineRx Ltd. - American Depositary Shares (BLRX) Description

BioLineRx Ltd. - American Depositary Shares Website: http://www.biolinerx.com/

News & Commentary Rss Feed

BioLineRX, Deep Pipeline, Excellent Dealmaking, Strong Alpha

BioLineRx (BLRX) Shows Strength: Stock Rises 7.4% - Tale of the Tape

Bioline RX (BLRX) Stock Gains on Positive Test Results, Coverage Initiation

JP Morgan: BioLineRx Will Outperform, Is Worth $5/Share On 'Promising Technology'

Benzinga's Top Initiations

BioLineRx Says Will Present Successful Results of Phase 1/2 Study of Novel Celiac Treatment

Research Underlying BioLineRx's Treatment of Type 1 Diabetes Wins Hebrew University's Kaye Innovatio

Research Underlying BioLineRx's Treatment of Type 1 Diabetes Wins Hebrew University's Kaye Innovation Award

BioLineRx Reports Peer-Reviewed Publication of Phase 1/2 Trial Results for Novel Treatment for Non-S

BioLineRx Reports Peer-Reviewed Publication of Phase 1/2 Trial Results for Novel Treatment for Non-Surgical Removal of Skin Lesions

BioLineRx Announces Will Present Safety, Efficacy Clinical Data for Novel Stem Cell Mobilization Tre

BioLineRx Announces Will Present Safety, Efficacy Clinical Data for Novel Stem Cell Mobilization Treatment at EHA

BioLineRX's (BLRX) CEO Kinneret Savitsky on Q1 2015 Results - Earnings Call Transcript

See More BLRX News...